共 50 条
- [32] Intravesical BCG therapy for non-muscle invasive bladder cancer ONKOUROLOGIYA, 2012, 8 (01): : 14 - 22
- [35] Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non-Muscle-Invasive Bladder Cancer JOURNAL OF UROLOGY, 2022, 208 (05): : 969 - 977
- [36] Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for Bacillus Calmette-Guerin-unresponsive Non-muscle invasive Bladder Cancer: Con EUROPEAN UROLOGY FOCUS, 2022, 8 (04): : 1121 - 1123
- [38] INTRAVESICAL GEMCITABINE IN COMBINATION WITH MITOMYCIN C AS SALVAGE TREATMENT IN RECURRENT NON-MUSCLE INVASIVE BLADDER CANCER JOURNAL OF UROLOGY, 2013, 189 (04): : E733 - E733
- [39] Transurethral resection combined with gemcitabine intravesical instillation in the treatment of non-muscle invasive bladder cancer in the elderly INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (09): : 6877 - 6885
- [40] SEQUENTIAL INTRAVESICAL GEMCITABINE-DOCETAXEL VERSUS BACILLUS CALMETTE-GUERIN (BCG) IN THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER: A PRELIMINARY COST-EFFECTIVENESS ANALYSIS JOURNAL OF UROLOGY, 2023, 209 : E542 - E542